Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 254, Issue 2, 1990, Pages 471-475

  Perrone, M H ^a   Hamel, L T ^a   Ferrari, R A ^a   Haubrich, D R ^a  

^a Sterling Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ADRENERGIC RECEPTOR AFFECTING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLONIDINE; CORYNANTHINE; DESIPRAMINE; DOPAMINE; IDAZOXAN; IMILOXAN; IMIPRAMINE; METHOXAMINE; MIANSERIN; NAPAMEZOLE; NORADRENALIN; PHENTOLAMINE; PIPEROXAN; PRAZOSIN; RADIOISOTOPE; RAUWOLSCINE; SEROTONIN; TOLAZOLINE; TRAZODONE; YOHIMBINE;

AMINE TRANSPORT; ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; VAS DEFERENS;

ADRENERGIC ALPHA-ANTAGONISTS; AMINO ACIDS; ANIMAL; BRAIN; CELLS, CULTURED; CLONIDINE; DIOXANES; IDAZOXAN; IMIDAZOLES; IMIPRAMINE; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; PRAZOSIN; RATS; RECEPTORS, ADRENERGIC, ALPHA; SYNAPTOSOMES; VAS DEFERENS;

EID: 0025079257     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)